Regression of hepatocellular carcinoma during vitamin K administration

World Journal of Gastroenterology

Volumn 11, Issue 42, 2005, Pages 6722-6724

  Nouso, Kazuhiro ^a   Uematsu, Shuji ^a   Shiraga, Kunihiro ^a   Okamoto, Ryoichi ^a   Harada, Ryo ^a   Takayama, Shoko ^a   Kawai, Wakako ^a   Kimura, Shigeru ^a   Ueki, Toru ^a   Okano, Nobuaki ^a   Nakagawa, Masahiro ^a   Mizuno, Motowo ^a   Araki, Yasuyuki ^a   Shiratori, Yasushi ^b  

^a HIROSHIMA CITY HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Regression; Vitamin K

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; INSULIN; LECTIN; TUMOR MARKER; VITAMIN K GROUP;

ADVANCED CANCER; AGED; AGING; ARTICLE; CANCER INHIBITION; CANCER REGRESSION; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIABETES MELLITUS; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MALE; TREATMENT RESPONSE; VITAMIN INTAKE;

EID: 30444449559     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i42.6722     Document Type: Article

References (15)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917
2. Leung TW, Johnson PJ. Systemic therapy for hepatocellular carcinoma. Semin Oncol 2001; 28: 514-520
3. Anthony PP. Hepatocellular carcinoma: an overview. Histopathology 2001; 39: 109-118
4. Lamson DW, Plaza SM. The anticancer effects of vitamin K. Altern Med Rev 2003; 8: 303-318
5. Wang Z, Wang M, Finn F, Carr BI. The growth inhibitory effects of vitamins K and their actions on gene expression. Hepatology 1995; 22: 876-882
6. Yaguchi M, Miyazawa K, Otawa M, Katagiri T, Nishimaki J, Uchida Y, Iwase O, Gotoh A. Kawanishi Y, Toyama K. Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody. Leukemia 1998; 12: 1392-1397
7. Nishimaki J, Miyazawa K, Yaguchi M, Katagiri T, Kawanishi Y, Toyama K, Ohyashiki K, Hashimoto S, Nakaya K, Takiguchi T. Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation. Leukemia 1999; 13: 1399-1405
8. Miyazawa K, Nishimaki J, Ohyashiki K, Enomoto S, Kuriya S, Fukuda R, Hotta T, Teramura M, Mizoguchi H, Uchiyama T. Omine M. Vitamin K2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan. Leukemia 2000; 14: 1156-1157
9. WH C. Efforts to explain spontaneous regression of cancer. J Surg Oncol 1981; 17: 201-209
10. Lin TJ, Liao LY, Lin CL, Shih LS, Chang TA, Tu HY, Chen RC, Wang CS. Spontaneous regression of hepatocellular carcinoma: a case report and literature review. Hepatogastroenterology 2004; 51: 579-582
11. Iiai T, Sato Y, Nabatame N, Yamamoto S, Makino S, Hatakeyama K. Spontaneous complete regression of hepatocellular carcinoma with portal vein tumor thrombus. Hepatogastroenterology 2003; 50: 1628-1630
12. Morimoto Y, Tanaka Y, Itoh T, Yamamoto S, Mizuno H, Fushimi H. Spontaneous necrosis of hepatocellular carcinoma: a case report. Dig Surg 2002; 19: 413-418
13. Abiru S, Kato Y, Hamasaki K, Nakao K, Nakata K, Eguchi K. Spontaneous regression of hepatocellular carcinoma associated with elevated levels of interleukin 18. Am J Gastroenterol 2002; 97: 774-775
14. Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H. Spontaneous regression of hepatocellular carcinoma with multiple lung metastases: a case report. Jpn J Clin Oncol 2001; 31: 454-458
15. Takeda Y, Togashi H, Shinzawa H, Miyano S, Ishii R, Karasawa T, Saito T, Saito K, Haga H, Matsuo T, Aoki M, Mitsuhashi H, Watanabe H, Takahashi T. Spontaneous regression of hepatocellular carcinoma and review of literature. J Gastroenterol Hepatol 2000; 15: 1079-1086